AstraZeneca’s Farxiga Authorized Generic Aims To Broaden Access As Medicare Price Cut Looms

 
• By Cathy Kelly
US Farxiga Sales were Up 61% In the First Quarter and 'Benefitted' from the Authorized Generic. • Source: Shutterstock

More from Pricing Debate

More from Market Access